Brandon Nispel from KeyBanc issued a price target of $18.00 for CMCSA on 2026-09-24 23:30:43.The adjusted price target was set to $18.00.At the time of the announcement, CMCSA was trading at $22.13.The overall price target consensus is at $29.00 with high price of $36.00, low price of $23.00, and median price is at $28.50.CMCSA currently...
KeyBanc analyst issues UNDERWEIGHT recommendation for CMCSA on September 24, 2026 11:30PM ET. The previous analyst...
Key Points - Amazon blocks Meta's Muse due to violations of terms of services - Retail...
Key Points - Pfizer faces loss of exclusivity but has new drug pipeline and cost-cutting plans...
Key Points - Women-led companies like BMY, HALO, TGT, NEO, and ROST are showing promising growth...
Brandon Nispel from KeyBanc issued a price target of $18.00 for CMCSA on 2026-09-24 23:30:43.The adjusted price target was set to $18.00.At the time of the announcement, CMCSA was trading...
from Wells Fargo issued a price target of $186.00 for JCI on 2026-09-24 20:17:04.The adjusted price target was set to $186.00.At the time of the announcement, JCI was trading at...
from UBS issued a price target of $33.00 for GM on 2026-09-24 13:32:00.The adjusted price target was set to $33.00.At the time of the announcement, GM was trading at $81.95.The...
Atul Maheswari from UBS issued a price target of $146.00 for UAL on 2026-09-24 12:44:10.The adjusted price target was set to $146.00.At the time of the announcement, UAL was trading...
from UBS issued a price target of $105.00 for DAL on 2026-09-24 12:43:43.The adjusted price target was set to $105.00.At the time of the announcement, DAL was trading at $81.535.The...
In the first quarter of 2025, the company faced revenue declines, largely due to Paxlovid, while operational expenses surged. Management is committed to enhancing R&D productivity and optimizing capital allocation,...
In a landscape of fluctuating markets and regulatory uncertainties, the company experienced a remarkable revenue surge, reaching $36,077 million. Despite operational challenges, net income stood at $7,713 million. Management emphasized...
In the bustling corridors of Merck, management reflects on a transformative quarter. With net income rising to 5,085 million, the company celebrates strategic wins in oncology and diabetes, driven by...
In 2025, the company embraced growth through increased research and development, despite rising operating expenses. A net income of $24,780 million marked a decline, reflecting challenges in a fluctuating market....
In the first quarter of 2025, the company experienced a 9% revenue growth, fueled by increased sales and services. Operating expenses rose, reflecting evolving cost structures, while net income showed...
Apple Inc. (NASDAQ: AAPL) continues to see its shares rally, defying Wall Street's previous skepticism regarding the company's position in the rapidly evolving artificial intelligence (AI) landscape. Concerns surrounding Apple's...
In a recent disclosure, Representative Rick W. Allen, a Republican from Georgia, has made headlines with his strategic investment moves, particularly in the semiconductor sector. On August 12th, he purchased...
In the fast-paced world of semiconductor companies, Micron Technology, Inc. (NASDAQ: MU) is making headlines with notable price surges and bullish forecasts. Over the past two years, the stock prices...
Alphabet Inc. experienced a notable decline of 3.8% in its stock valuation in a single trading session, despite the absence of an earnings warning, guidance adjustments, or regulatory news that...
Nvidia Corp (NASDAQ: NVDA) has emerged as a giant within the artificial intelligence sector, achieving impressive fiscal results without directly operating the manufacturing facilities (fabs) that produce its chips. The...
